Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined with Either Raltegravir or Tenofovir Disoproxil Fumarate /Emtricitabine in the Neat 001/Anrs 143 Trial
dc.rights.license | open | en_US |
dc.contributor.author | AMMASSARI, A. | |
dc.contributor.author | STOHR, W. | |
dc.contributor.author | ANTINORI, A. | |
dc.contributor.author | MOLINA, J. M. | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | SCHWIMMER, Christine | |
dc.contributor.author | DOMINGO, P. | |
dc.contributor.author | THALME, A. | |
dc.contributor.author | DI PIETRO, M. | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | WALLET, Cedrick | |
dc.contributor.author | POZNIAK, A. | |
hal.structure.identifier | Bordeaux population health [BPH] | |
dc.contributor.author | RICHERT, Laura | |
dc.contributor.author | RAFFI, F. | |
dc.date.accessioned | 2020-10-19T08:10:07Z | |
dc.date.available | 2020-10-19T08:10:07Z | |
dc.date.issued | 2018-08-27 | |
dc.identifier.issn | 1944-7884 (Electronic) 1525-4135 (Linking) | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/11405 | |
dc.description.abstractEn | BACKGROUND: The NEAT 001/ANRS 143 trial demonstrated non-inferiority of darunavir-ritonavir combined with either raltegravir (RAL+DRV/r) or tenofovir disoproxil fumarate/emtricitabine (TDF/FTC+DRV/r) in HIV-positive, antiretroviral-naive adults. In post-hoc analyses however, RAL+DRV/r showed inferiority in patients with baseline CD4+ <200/mm and HIV-1 RNA >/=100,000 copies/mL. This pre-planned ancillary study was conducted to assess whether differences in adherence might explain efficacy results SETTING | |
dc.language.iso | EN | en_US |
dc.subject.en | SISTM | |
dc.title.en | Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined with Either Raltegravir or Tenofovir Disoproxil Fumarate /Emtricitabine in the Neat 001/Anrs 143 Trial | |
dc.title.alternative | J Acquir Immune Defic Syndr | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1097/qai.0000000000001834 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
dc.identifier.pubmed | 30153121 | en_US |
bordeaux.journal | Journal of acquired immune deficiency syndromes (1999) | en_US |
bordeaux.page | 481-490 | en_US |
bordeaux.volume | 79 | en_US |
bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
bordeaux.issue | 4 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.team | SISTM_BPH | |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
hal.export | false | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20acquired%20immune%20deficiency%20syndromes%20(1999)&rft.date=2018-08-27&rft.volume=79&rft.issue=4&rft.spage=481-490&rft.epage=481-490&rft.eissn=1944-7884%20(Electronic)%201525-4135%20(Linking)&rft.issn=1944-7884%20(Electronic)%201525-4135%20(Linking)&rft.au=AMMASSARI,%20A.&STOHR,%20W.&ANTINORI,%20A.&MOLINA,%20J.%20M.&SCHWIMMER,%20Christine&rft.genre=article |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |